In human ErbB2 tolerant mice, while HuRT is clearly the most effective in hampering the growth of transplantable tumors expressing the human ErbB2 ortholog [25], it was equally effective as RHuT in halting human ErbB2+ autochthonous mammary carcinomas (Table 2) [24]. Here, ERBB2 is linked to breast carcinoma.